Nikhil Abreo

DMD | Dentist



  
  1412 Fairmount Ave, Philadelphia
  Pennsylvania, 19130-2908

  215-235-9600    Maps & Directions
Nikhil Abreo is a Philadelphia, Pennsylvania based Dentist who is specialized in General Practice Dentistry. He may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. His current practice location is 1412 Fairmount Ave, Philadelphia. Patients can reach him at 215-235-9600.
Nikhil Abreo is the primary dental care provider for patients of all ages. He is responsible for the diagnosis, treatment, management and overall coordination of services related to patients' oral health needs.
Complete Profile:
Nikhil Abreo speciality, credentials, practice address, contact phone number and fax are as below. Patients can directly walk in or can call on the below given phone number for appointment.
Name: Nikhil Abreo
Specialization: Dentist
Gender:Male
Credentials: DMD
Accepts Medicare Assignment:May Accept
Practice Address:1412 Fairmount Ave, Philadelphia,
Pennsylvania, 19130-2908
Phone:215-235-9600
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
PAC ID: 6002187218
Enrollment ID: I20170807002263
NPI Number: 1720508369
NPI Enumeration Date: 25 Jun, 2017
NPI Last Update On: 14 Jul, 2017

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 1412-22 Fairmount Avenue,
Philadelphia, Pennsylvania
Zip: 19130-2908
Phone Number: 215-235-9600
Fax Number: 215-232-4093
Patients can reach Nikhil Abreo at 1412 Fairmount Ave, Philadelphia, Pennsylvania or can call to book an appointment on 215-235-9600. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.

Comments/ Reviews: